These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 32186058)

  • 21. Clinical antitumor application and pharmacological mechanisms of Dahuang Zhechong Pill.
    Tian Y; Ma B; Yu S; Li Y; Pei H; Tian S; Zhao X; Liu C; Zuo Z; Wang Z
    Chin Herb Med; 2023 Apr; 15(2):169-180. PubMed ID: 37265776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Safety of Dahuang Zhechong Pill in Silicosis: A Randomized Controlled Trial.
    Tang WY; Liang JT; Wu J; Liu L; Lu MZ; He XY; Wu LJ; Jiang HY; Wang F; Meng X; Li SP
    Evid Based Complement Alternat Med; 2021; 2021():4354054. PubMed ID: 34840587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of Huangqi Zhechong decoction on liver fibrosis in rat.
    Dang SS; Jia XL; Cheng YA; Chen YR; Liu EQ; Li ZF
    World J Gastroenterol; 2004 Aug; 10(15):2295-8. PubMed ID: 15259087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of the pharmacodynamic substances in dahuang zhechong pill that inhibit energy metabolism.
    Ni ZH; Wu L; Cao KX; Zhang XQ; Wang DY; Zeng YW; Liang LL; Qiu XD; Guo RS; Cheng HB; Chen ZP
    J Ethnopharmacol; 2020 Apr; 251():112332. PubMed ID: 31669443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous determination of nineteen compounds of Dahuang zhechong pill in rat plasma by UHPLC-MS/MS and its application in a pharmacokinetic study.
    Wu L; Du S; Yang F; Ni Z; Chen Z; Liu X; Wang Y; Zhou Q; Li W; Qin K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 May; 1151():122200. PubMed ID: 32526664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Dahuang zhechong formula on liver fibrosis in patients with chronic hepatitis B: a meta-analysis.
    Wei F; Lang Y; Gong D; Fan Y
    Complement Ther Med; 2015 Feb; 23(1):129-38. PubMed ID: 25637160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of acupuncture intervention on hepatic platelet-derived growth factor signaling pathway in CCl4-induced hepatic fibrosis rats].
    Kong DS; Ma J; Lu Y; Ni GX; Ni CY; Zhang XJ; Wang AY; Chen WX; Zheng SZ
    Zhen Ci Yan Jiu; 2012 Apr; 37(2):87-92. PubMed ID: 22764591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased expression of p38 MAPK mediates protective effects of hydrogen sulfide on hepatic fibrosis.
    Fan HN; Wang HJ; Ren L; Ren B; Dan CR; Li YF; Hou LZ; Deng Y
    Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):644-52. PubMed ID: 23543448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dahuang Zhechong Pill Combined with Doxorubicin Induces Cell Death through Regulating Energy Metabolism in Human Hepatocellular Carcinoma Cells.
    Wu L; Zhao J; Cai H; Wang J; Chen Z; Li W; Liu X
    Evid Based Complement Alternat Med; 2017; 2017():6279576. PubMed ID: 28785292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Aldosterone antagonist inhibits fibrosis-induced NOX4 protein expression in hepatic cells and tissues of rats].
    Zhang WY; Li Y; Li T; Ning ZW; Li W; Li X
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jul; 21(7):519-23. PubMed ID: 24074711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study on the material basis of Dahuang Zhechong pill of anti-hepatoma effect by promoting vascular normalization.
    Chen H; Yang F; Fu C; Zhang Z; Xu K; Lu S; Chen Z; Wu L; Li W
    Biomed Chromatogr; 2022 May; 36(5):e5305. PubMed ID: 34967034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative Effect Observation and Clinical Study of Dahuang Zhechong Pills from
    Hou S; Bin C
    Comput Intell Neurosci; 2022; 2022():2998825. PubMed ID: 35528360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-atherosclerotic effects of divided functional recipes of Dahang Zhechong pill in rabbits].
    Ji YY; Liu JT; Gou-Wei ; Wang ZD
    Zhongguo Zhong Yao Za Zhi; 2006 Nov; 31(22):1886-90. PubMed ID: 17285991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on anti-atherosclerotic mechanisms of divided functional recipes of dahuang zhechong pill in rabbits].
    Ji YY; Liu JT; Wang ZD; Li JL; Li XK
    Zhongguo Zhong Yao Za Zhi; 2007 Jun; 32(11):1077-81. PubMed ID: 17672348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways.
    Huang Q; Zhang X; Bai F; Nie J; Wen S; Wei Y; Wei J; Huang R; He M; Lu Z; Lin X
    Int Immunopharmacol; 2019 Jan; 66():41-51. PubMed ID: 30419452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the liver protection and toxicity of Da-Huang-Zhe-Chong pill in rats.
    Xing XY; Zhao YL; Jia L; Kong WJ; Zhong YW; Wang JB; Zhang P; Ren HL; Xiao XH
    Pharm Biol; 2012 Mar; 50(3):344-50. PubMed ID: 22103766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of signaling pathway of long non-coding RNA growth arrest-specific transcript 5/microRNA-200c-3p/angiotensin converting enzyme 2 in the apoptosis of human lung epithelial cell A549 in acute respiratory distress syndrome].
    Li HB; Zi PP; Shi HJ; Gao M; Sun RQ
    Zhonghua Yi Xue Za Zhi; 2018 Nov; 98(41):3354-3359. PubMed ID: 30440128
    [No Abstract]   [Full Text] [Related]  

  • 38. Dahuang Zhechong Pill suppresses colorectal cancer liver metastasis via ameliorating exosomal CCL2 primed pre-metastatic niche.
    Chen C; Yao X; Xu Y; Zhang Q; Wang H; Zhao L; Wen G; Liu Y; Jing L; Sun X
    J Ethnopharmacol; 2019 Jun; 238():111878. PubMed ID: 30986521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GAS5 promotes myocardial apoptosis in myocardial ischemia-reperfusion injury via upregulating LAS1 expression.
    Liu SD; Meng WX; Xu L; Chi C; Sun X; Liu HY
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8447-8453. PubMed ID: 30556886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
    Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
    J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.